B Cells in Idiopathic Pulmonary Fibrosis: Targeting Immune Cells with Antifibrotic Agents
Overview
Molecular Biology
Authors
Affiliations
Pulmonary fibrosis: pathogenesis and therapeutic strategies.
Wang J, Li K, Hao D, Li X, Zhu Y, Yu H MedComm (2020). 2024; 5(10):e744.
PMID: 39314887 PMC: 11417429. DOI: 10.1002/mco2.744.
Enzel D, Kriventsov M, Sataieva T, Malygina V Int J Mol Sci. 2024; 25(16).
PMID: 39201632 PMC: 11355055. DOI: 10.3390/ijms25168946.
Sun Z, Lou Y, Hu X, Song F, Zheng X, Hu Y BMC Pulm Med. 2023; 23(1):149.
PMID: 37118713 PMC: 10148423. DOI: 10.1186/s12890-023-02424-5.
Potential of resveratrol in the treatment of interstitial lung disease.
Huo R, Huang X, Yang Y, Yang Y, Lin J Front Pharmacol. 2023; 14:1139460.
PMID: 37089962 PMC: 10117935. DOI: 10.3389/fphar.2023.1139460.
Nguyen J, Armstrong B, Cowman S, Tomer Y, Veerabhadraiah S, Beers M Front Pharmacol. 2022; 13:875887.
PMID: 35571100 PMC: 9094740. DOI: 10.3389/fphar.2022.875887.